Maternal methadone dose, placental methadone concentrations, and neonatal outcomes.
暂无分享,去创建一个
[1] M. Huestis,et al. Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry. , 2009, Journal of analytical toxicology.
[2] M. Huestis,et al. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry , 2009, Analytical and bioanalytical chemistry.
[3] M. Huestis,et al. A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium , 2009, Analytical and bioanalytical chemistry.
[4] J. Atta-Politou,et al. Validated method for the simultaneous determination of methadone and its main metabolites (EDDP and EMDP) in plasma of umbilical cord blood by gas chromatography-mass spectrometry. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[5] R. Nanan,et al. Methadone Maintenance and Breastfeeding in the Neonatal Period , 2008, Pediatrics.
[6] M. Huestis,et al. Methadone Maintenance and Breastfeeding in the Neonatal Period , 2008, Pediatrics.
[7] M. Huestis,et al. Validation of a LC-APCI-MS/MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[8] M. Huestis,et al. Concentrations of Methadone in Breast Milk and Plasma in the Immediate Perinatal Period , 2007, Journal of human lactation : official journal of International Lactation Consultant Association.
[9] S. Pichini,et al. Neonatal withdrawal syndrome after chronic maternal drinking of mate. , 2007, Therapeutic drug monitoring.
[10] R. Pacifici,et al. Confirmation of gestational exposure to alprazolam by analysis of biological matrices in a newborn with neonatal sepsis , 2007, Clinical toxicology.
[11] H. Jones,et al. Mood disorders affect drug treatment success of drug-dependent pregnant women. , 2007, Journal of substance abuse treatment.
[12] A. Bermejo,et al. Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine and alprazolam in human plasma by liquid chromatography-electrospray ionization mass spectrometry. , 2006, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[13] M. Strolin Benedetti,et al. Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations , 2005, Expert opinion on drug metabolism & toxicology.
[14] B. Lester,et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. , 2005, Drug and alcohol dependence.
[15] R. Pacifici,et al. Prenatal exposure to arecoline (areca nut alkaloid) and birth outcomes , 2005, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[16] H. Jones,et al. Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[17] G. Hankins,et al. Bidirectional transfer of methadone across human placenta. , 2005, Biochemical pharmacology.
[18] H. Jones,et al. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. , 2004, Drug and alcohol dependence.
[19] E. Kharasch,et al. Role of hepatic and intestinal cytochrome P450 3A and 2B6 in the metabolism, disposition, and miotic effects of methadone , 2004, Clinical pharmacology and therapeutics.
[20] R. Couch,et al. Can methadone concentrations predict the severity of withdrawal in infants at risk of neonatal abstinence syndrome? , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.
[21] G. Hankins,et al. Methadone metabolism by human placenta. , 2004, Biochemical pharmacology.
[22] J. Keelan,et al. Drug Transfer and Metabolism by the Human Placenta , 2004, Clinical pharmacokinetics.
[23] J. Kinsella. Meconium aspiration syndrome: is surfactant lavage the answer? , 2003, American journal of respiratory and critical care medicine.
[24] M. Huestis,et al. Drug abuse's smallest victims: in utero drug exposure. , 2002, Forensic science international.
[25] J. Spagnoli,et al. Plasma concentrations of the enantiomers of methadone and therapeutic response in methadone maintenance treatment. , 2000, Drug and alcohol dependence.
[26] Kirsi Vähäkangas,et al. Ex vivo perfusion of the human placental cotyledon: implications for anesthetic pharmacology , 2000 .
[27] M. S. Ching,et al. Fetal hepatic drug elimination. , 1999, Pharmacology & therapeutics.
[28] A. Negrusz,et al. Determination of drugs of abuse in meconium. , 1998, Journal of chromatography. B, Biomedical sciences and applications.
[29] P. Friedmann,et al. Relationships Between Maternal Methadone Dosage, Maternal-Neonatal Methadone Levels, and Neonatal Withdrawal , 1993, Obstetrics and gynecology.
[30] N. Buchanan,et al. Methadone levels and neonatal withdrawal , 1991, Journal of paediatrics and child health.
[31] H Nau,et al. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. , 1985, Developmental pharmacology and therapeutics.
[32] C. Pippenger,et al. Pharmacologic observations on the neonatal withdrawal syndrome. , 1976, The Journal of pediatrics.
[33] M. Strauss,et al. Methadone maintenance during pregnancy: pregnancy, birth, and neonate characteristics. , 1974, American journal of obstetrics and gynecology.